BBI Life Sciences

China National Pharmaceutical Group Co., Ltd (Sinopharm) is reportedly considering a bid to acquire Shanghai-based BBI Life Sciences Corp., with a potential deal valued at over USD 1 billion, according to Bloomberg. The news cites insider sources stating Sinopharm has held preliminary talks with BBI’s founding Wang family, while other…